Ultrahuman launches M2 Live glucose platform in the U.S. with Abbott’s Lingo™ continuous glucose monitor

June 18, 2026

[18 June 2026] – Ultrahuman today launched M2 Live, its category-defining metabolic health platform, in the U.S, making glucose tracking accessible to millions of health-conscious adults.

Among the first platforms to integrate glucose data from Lingo™, Abbott's over-the-counter continuous glucose monitor (CGM), M2 Live removes the barriers that have long kept metabolic health out of reach for many in the U.S. There’s no prescription and a lower cost, with sensors starting at just $99/month on subscription.

Ultrahuman first brought CGM to people without diabetes back in 2021, creating an entirely new category of metabolic health monitoring. M1 Live’s clinically validated Metabolic Score was built on one of the largest real-world, free-living sleep and metabolism datasets ever assembled.

Five years on, Ultrahuman M2 Live sets a new benchmark and becomes one of the most affordable wearable metabolic health platforms in the U.S. It integrates glucose data from Lingo – Abbott's CGM for people 18+years old not on insulin interested in improving their overall health and wellness, including those with prediabetes.

Introducing M2 Live: Metabolic Insights With a Difference

M2 Live is powerful on its own – streaming glucose data into the Ultrahuman app’s metabolic insights engine. But inside Ultrahuman's full-stack health ecosystem, it's transformative.

Sleep, stress, activity, and recovery all shape how the body regulates glucose – but unlike other metabolic health platforms, M2 Live doesn't look at glucose in isolation. 

Continuous health markers from the Ultrahuman Ring and 100+ blood biomarkers from Blood Vision combine with metabolic data to reveal the why behind every spike, dip, and trend. This unparalleled insight is driven by Jade AI, Ultrahuman’s real-time biointelligence system that connects the dots between metabolic health data and lifestyle markers.

The opportunity is enormous. Only 1 in 8 US adults is metabolically healthy, driving the world's most costly chronic diseases, from Type 2 diabetes to cardiovascular conditions. M2 Live helps people understand how their body responds to food, exercise, stress, and sleep in real time – and those insights can support weight loss, focus, sleep, and add healthy years to their life.

"Ultrahuman created an entirely new category: glucose monitoring for wellness," said Mohit Kumar, Founder and CEO of Ultrahuman. "By combining M2 Live with glucose data from Abbott’s Lingo people can better understand how to make healthy change and improve their metabolic health.”

"For our US customers, the over-the-counter solution with Lingo means Ultrahuman M2 Live removes the friction of needing a physician for people to access their glucose data and insights," added Hussain Ahamed, responsible for strategic partnerships in the Americas.

The Most Complete Metabolic Health Platform Ever Built

Ultrahuman M2 Live combines glucose data from Lingo with Ultrahuman's metabolic intelligence engine – the product of five years of research, close to ten million logged meals, and partnerships with the world's most respected health institutions. It offers:

  • Clinically Validated Metabolic Score: A daily 0–100 score reflecting glucose regulation, validated in a rigorous multi-site clinical study against gold-standard biomarkers of insulin resistance and glucose tolerance. 
  • Jade AI Biointelligence: The world's first real-time health AI, Jade connects glucose patterns with sleep, HRV, activity, recovery, and skin temperature from Ultrahuman Ring.
  • Glucose Tracking and Spike Detection: Glucose visibility with intelligent alerts when readings exceed target ranges.
  • Food Score: A 1-to-10 rating showing how different foods affect glucose levels, enabling data-driven dietary decisions personalized to an individual's unique biology. 
  • Fueling Score: Optimize sports and workout performance by understanding how glucose availability impacts exercise output, endurance, and recovery in real time.
  • OGDb: The World’s largest open glucose database, created by Ultrahuman, showing live anonymized data of Ultrahuman users’ average scores for different foods.

A World-Class Clinical Research Foundation

By innovating early in metabolic health, Ultrahuman has built one of the world's largest real-world datasets and partnered with leading institutions to validate its platform.

  • Metabolic Score Validation (2024): A multi-site study across nine clinical centres confirmed the Metabolic Score reliably differentiates between non-diabetic and pre-diabetic individuals. Published in Nature, one of the few consumer health metrics with this level of peer-reviewed validation. [Nature]
  • Stanford Sleep–Metabolism Study (2026): Developed with Stanford's Snyder Lab, Bangor University, and La Trobe University, the study analysed 227,860 nights from 5,859 adults across 100 countries – revealing that sleep timing consistency is the single strongest predictor of metabolic health. [MedRXIV]
  • Mayo Clinic GLP-1 Study (ongoing): A clinical trial evaluating glycaemic and physiological changes in non-diabetic patients on GLP-1 medications – a research portfolio that rivals companies many times Ultrahuman's size. [Mayo.edu]

Pricing and Availability

Ultrahuman M2 Live launches in the US via ultrahuman.com from today. Each Lingo biosensor can be worn for up to 14 days.* For full safety information (risks and benefits) about Lingo, visit https://www.hellolingo.com/safety-information

Single sensor: $129 | Monthly subscription: $99 

*A study was conducted to assess the biosensor life, where 77.1% of biosensors lasted the full 14 days. In other words, when using the product per the package labeling, approximately 22.9% of biosensors may not last for the full 14 days. 14.7% of biosensors may last less than 11 days.

About Ultrahuman

Ultrahuman is one of the world's leading health optimization platforms and the #2 smart ring maker globally (Counterpoint Research). Its product ecosystem – Ring AIR, Ring PRO, Blood Vision (100+ biomarker testing), Ultrahuman Home, and the M1 Live/M1 Live CGM platforms – is connected by Jade, the world's first real-time biointelligence AI. Named one of TIME's World's Top HealthTech Companies in 2025, Ultrahuman serves 700,000+ users across more than 100 countries and has conducted clinical research with Stanford, Mayo Clinic, and other leading institutions. ultrahuman.com | science.ultrahuman.com.

Media contact: press@ultrahuman.com

Copyright © 2023 Ultrahuman . All rights reserved.